Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: CANCER ; CELLS ; SURVIVAL ; carcinoma ; CELL ; LUNG ; INFORMATION ; lung cancer ; LUNG-CANCER ; GENE ; PROTEIN ; TISSUE ; PATIENT ; MACROPHAGES ; MARKER ; prognosis ; CONTRAST ; LYMPH-NODES ; STAGE ; PROGRESSION ; HIGH-RISK ; LOCALIZATION ; HEAD ; HIGH-LEVEL ; non-small cell lung cancer ; CATHEPSIN-B ; STEFIN-A ; TUMOR TISSUE ; LEVEL ; IMMUNOHISTOCHEMICAL ANALYSIS ; NSCLC ; CYSTEINE PROTEASE ; RELEVANCE ; macrophage ; PREDICTOR ; inflammatory cells ; biological markers ; cystatin ; cathepsin ; CYSTEINE PROTEINASE-INHIBITOR ; ENDOGENOUS INHIBITORS ; PROTEASE INHIBITORS ; stefin
    Abstract: Cystatins regulate tumour-associated cysteine proteases, however, their role in tumour progression is not clear yet. To assess their relevance in the progression of nonsmall cell lung cancer (NSCLC) the protein level, cysteine protease activity (CPI) and localization of type I (stefins A and B) and type H (C, E/M and F) cystatins were defined in tumours and control lung counterparts from 165 patients. The medians of CPI activity, stefins A and B were significantly greater in tumour than in lung tissue (2.1-fold, 1.7-fold, 1.2-fold, respectively, all p 〈 0.001). The median levels of cystatin C and cystatin E/M were lower in tumour tissue (0.9-fold, p=0.06; 0.6-fold, p 〈 0.01). In all the samples the levels of cystatin F were below the detection limit. Immunohistochemical analysis revealed the presence of all cystatins in tumour cells and infiltrated inflammatory cells such as macrophages and neutrophils. In univariate survival analysis patients with high levels of stefin A, stefin B and CPI activity exhibited a better survival probability (p=0.05, p=0.05, p 〈 0.01, respectively). In contrast, cystatins C and E/M provided no prognostic information. In multivariate analysis the most powerful predictor of survival was the pTNM stage (p 〈 0.0001; RR 3.5), followed by stefin A, stefin B and CPI activity (all p=0.03; RR 1.5). Our results suggest that only stefins A and B, i.e. type I cystatins, are up-regulated in lung tumours and thus able to counteract harmful tumour-associated proteolytic activity. As biological markers they may add independent prognostic information for better assessment of low- and high-risk patients with NSCLC
    Type of Publication: Journal article published
    PubMed ID: 16969475
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...